Orchid Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ORCHPHARMA BSE: 524372

₹997.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #59 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Orchid Pharma Limited (this stock)	5,057	148.1	7.9%	38.4%	—	50	20	32

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2025). EBITDA = PBT + interest + depreciation.

Enterprise value

₹5,215 Cr

EV / EBITDA

58.0x

EV / Sales

5.53x

Market cap / Sales

5.36x

Earnings yield

0.68%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 314 Cr, up 66.4% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 12 Cr, down 34.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	304	12	12	₹1.9900
March 31, 2026	238	31	31	₹5.4500
Dec. 31, 2025	207	-6	-6	₹-1.1500
Sept. 30, 2025	194	2	2	₹0.4400
June 30, 2025	173	18	18	₹3.5900
March 31, 2025	237	28	28	₹
Dec. 31, 2024	217	24	24	₹4.7100
Sept. 30, 2024	223	26	26	₹5.0500
June 30, 2024	244	29	29	₹5.7400
March 31, 2024	217	30	33	₹6.8600
Dec. 31, 2023	221	31	31	₹6.4200
Sept. 30, 2023	199	20	20	₹4.4000
June 30, 2023	183	11	11	₹2.6400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	314	251	218	209	189	227	231	252	230	228	207	185	212
Operating revenue	304	238	207	194	173	217	223	244	217	221	199	183	210
Other income	10	13	11	15	16	10	8	8	13	7	8	2	2
Operating expenses	289	208	204	194	159	191	193	211	188	185	175	161	170
Operating profit	15	30	3	-1	14	26	30	33	29	36	24	22	40
Operating profit margin	4.9%	12.6%	1.4%	-0.3%	8.2%	12.1%	13.3%	13.6%	13.3%	16.3%	11.9%	12.1%	18.9%
Depreciation	11	11	9	9	9	9	9	8	8	9	8	8	7
Interest	2	2	3	4	3	4	3	3	3	4	4	6	7
Exceptional items, gain / (loss)	—	1	-7	—	—	—	—	—	—	—	—	—	39
Profit before tax	12	31	-6	2	18	24	26	29	30	31	20	11	66
Tax	—	—	—	—	—	—	—	—	-3	—	—	—	—
Net profit	12	31	-6	2	18	24	26	29	33	31	20	11	—
EPS	1.99	5.45	-1.15	0.44	3.59	4.71	5.05	5.74	6.86	6.42	4.40	2.64	16.15
Net profit (TTM)	39	45	39	70	97	112	118	113	95	—	—	—	—
EPS (TTM)	6.73	8.33	7.59	13.79	19.09	22.36	24.07	23.42	20.32	29.61	24.84	19.63	13.54

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2025	922	106	106
March 31, 2024	819	92	95
March 31, 2023	666	55	54

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	8.1%	13.6%	867^†	—	850^†	685^†	566^†	457^†	530^†	601^†	669^†	—
Operating revenue	6.8%	12.5%	811^†	922	819	666	557^†	451^†	505^†	584^†	649^†	764^†
Other income	—	—	55^†	—	30^†	19^†	9^†	6^†	24^†	17^†	20^†	—
Operating expenses	—	—	765^†	—	709^†	582^†	500^†	393^†	552^†	—	—	—
Operating profit	-17.9%	-4.4%	46^†	—	111^†	84^†	57^†	58^†	-46^†	—	—	—
Operating profit margin	—	—	5.7%^†	—	13.5%^†	12.6%^†	10.3%^†	12.8%^†	-9.2%^†	—	—	—
Depreciation	—	—	38^†	—	33^†	55^†	87^†	109^†	126^†	130^†	133^†	—
Interest	—	—	12^†	—	16^†	32^†	32^†	51^†	2^†	—	—	331^†
Exceptional items, gain / (loss)	—	—	-7^†	—	0^†	39^†	0^†	0^†	0^†	38^†	0^†	-86^†
Profit before tax	-6.5%	—	45^†	106	92	55	-53^†	-96^†	-150^†	-101^†	-402^†	-445^†
Tax	—	—	—	—	—	—	—	—	—	—	-48^†	-48^†
Net profit	-5.9%	—	45^†	106	95	54	—	—	-150^†	-101^†	-354^†	—
EPS	-14.9%	—	8.33^†	—	20.32^†	13.54^†	-1.18^†	-28.71^†	-16.05^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	5.7%^†	—	13.5%^†	12.6%^†	10.3%^†	12.8%^†	-9.2%^†	—	—	—
EBIT margin	7.1%^†	—	13.2%^†	13.1%^†	-3.7%^†	-9.9%^†	-29.3%^†	—	—	-15.0%^†
PBT margin	5.6%^†	11.6%	11.2%	8.3%	-9.5%^†	-21.3%^†	-29.6%^†	-17.3%^†	-62.0%^†	-58.3%^†
Net margin	5.6%^†	11.6%	11.6%	8.1%	—	—	-29.6%^†	-17.3%^†	-54.6%^†	—
Interest coverage	4.73x^†	—	6.61x^†	2.71x^†	-0.65x^†	-0.87x^†	-75.43x^†	—	—	-0.35x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	—	3.31x	—	—	—	—	—	—	—	—
Quick ratio	—	1.94x	—	—	—	—	—	—	—	—
Debt to equity	—	0.13x	—	—	—	—	—	—	—	—
Return on equity	—	8.0%	—	—	—	—	—	—	—	—
Return on assets	—	6.3%	—	—	—	—	—	—	—	—
Return on capital employed	—	—	—	—	—	—	—	—	—	—
Asset turnover	—	0.54x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2025	27	-37	25	69	-41
March 31, 2024	131	-316	167	55	76
March 31, 2023	13	-27	31	85	-71
March 31, 2022	90	113	-217	14	75

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	—	—	—	—	—	—	—	—	—	—
March 31, 2025	1,697	1,324	1,273	43	132	786	237	16	612	326
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.